Axcelis Technologies, Inc. (NASDAQ:ACLS) Given Consensus Rating of “Hold” by Brokerages

Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) have received an average rating of “Hold” from the seven research firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $132.20.

A number of brokerages have weighed in on ACLS. Craig Hallum lowered Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 price target on the stock. in a research note on Friday, August 7th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Friday, August 7th. Finally, Bank of America increased their target price on Axcelis Technologies from $130.00 to $156.00 and gave the stock an “underperform” rating in a research report on Tuesday, June 23rd.

Institutional Investors Weigh In On Axcelis Technologies

Several hedge funds have recently modified their holdings of the stock. KERR FINANCIAL PLANNING Corp increased its position in Axcelis Technologies by 3.5% during the 2nd quarter. KERR FINANCIAL PLANNING Corp now owns 2,225 shares of the semiconductor company’s stock worth $422,000 after purchasing an additional 75 shares in the last quarter. Parallel Advisors LLC lifted its position in Axcelis Technologies by 22.0% during the first quarter. Parallel Advisors LLC now owns 665 shares of the semiconductor company’s stock valued at $62,000 after buying an additional 120 shares in the last quarter. Larson Financial Group LLC lifted its position in Axcelis Technologies by 17.8% during the fourth quarter. Larson Financial Group LLC now owns 933 shares of the semiconductor company’s stock valued at $75,000 after buying an additional 141 shares in the last quarter. Empowered Funds LLC grew its stake in Axcelis Technologies by 0.5% during the first quarter. Empowered Funds LLC now owns 39,087 shares of the semiconductor company’s stock worth $3,638,000 after buying an additional 199 shares during the period. Finally, Allworth Financial LP grew its stake in Axcelis Technologies by 39.1% during the fourth quarter. Allworth Financial LP now owns 762 shares of the semiconductor company’s stock worth $61,000 after buying an additional 214 shares during the period. 89.98% of the stock is owned by institutional investors and hedge funds.

Axcelis Technologies Stock Performance

Shares of NASDAQ ACLS opened at $105.31 on Thursday. The company has a market cap of $3.25 billion, a PE ratio of 35.34, a price-to-earnings-growth ratio of 3.47 and a beta of 1.86. Axcelis Technologies has a 12 month low of $73.60 and a 12 month high of $193.78. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.90 and a quick ratio of 3.21. The company has a 50-day simple moving average of $128.95 and a 200-day simple moving average of $130.96.

Axcelis Technologies (NASDAQ:ACLS) last announced its quarterly earnings data on Thursday, August 6th. The semiconductor company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.17. Axcelis Technologies had a net margin of 10.71% and a return on equity of 11.69%. The business had revenue of $215.18 million for the quarter, compared to the consensus estimate of $205.03 million. During the same quarter in the prior year, the firm posted $1.13 earnings per share. The company’s quarterly revenue was up 10.6% compared to the same quarter last year. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. On average, equities analysts anticipate that Axcelis Technologies will post 3.39 earnings per share for the current year.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc is a semiconductor equipment company that designs, manufactures and services ion implantation systems used in the production of semiconductor devices. Its equipment modifies the electrical properties of silicon wafers by implanting precisely controlled ions, an important step in manufacturing power semiconductors, memory products and other integrated circuits.

The company’s primary product family is the Purion platform, which includes systems designed for high-current, medium-current and high-energy implantation applications.